Patients with underlying severe heart disease (e.g. There is some evidence from post-marketing data and published literature of rare occurrences of myocardial ischaemia associated with salbutamol. Severe exacerbations of asthma must be treated in the normal way.Ĭardiovascular effects may be seen with sympathomimetic drugs, including salbutamol. higher doses of inhaled corticosteroid or a course of oral corticosteroid). In this situation the patient should be assessed and consideration given to the need for increased anti-inflammatory therapy (e.g. The patient should be instructed to seek medical advice if short-acting relief bronchodilator treatment becomes less effective, or more inhalations than usual are required. Increasing use of bronchodilators, in particular short-acting inhaled beta- 2-agonists, to relieve symptoms, indicates deterioration of asthma control. If a previously effective dose of inhaled salbutamol fails to give relief lasting at least three hours, the patient should be advised to seek medical advice. The dosage or frequency of administration should only be increased on medical advice. Physicians should consider using the maximum recommended dose of inhaled corticosteroid and/or oral corticosteroid therapy in these patients. Severe asthma requires regular medical assessment, including lung-function testing, as patients are at risk of severe attacks and even death. Patients should be warned that they may experience a different taste upon inhalation compared to their previous inhaler.īronchodilators should not be the only or main treatment in patients with severe or unstable asthma. Patients inhaler technique should be checked to make sure that aerosol actuation is synchronised with inspiration of breath for optimum delivery of drug to the lungs. Reliance on such frequent supplementary use, or a sudden increase in dose, indicates poorly controlled or deteriorating asthma (see section 4.4). On-demand use of Ventolin Evohaler should not exceed 8 inhalations in any 24 hours. The Babyhaler spacer device may be used to facilitate administration to children under 5 years of age. The usual dosage for children under the age of 12 years: up to two inhalations 4 times daily. The dose may be increased to two inhalations if required. The usual dosage for children under the age of 12 years: one inhalation (100 micrograms) before challenge or exertion. Prevention of allergen or exercise-induced bronchospasm The dose may be increased to two inhalations if required.Ĭhildren aged 12 years and over: dose as per adult population. The usual dosage for children under the age of 12 years: one inhalation (100 micrograms). To prevent allergen- or exercise-induced symptoms, two inhalations should be taken 10-15 minutes before challenge.įor chronic therapy, two inhalations up to four times a day. This may be increased to two inhalations if necessary. Ventolin Evohaler may be used with a Volumatic spacer device by patients who find it difficult to synchronise aerosol actuation with inspiration of breath.įor the relief of acute asthma symptoms including bronchospasm, one inhalation (100 micrograms) may be administered as a single minimum starting dose. Ventolin Evohaler is for oral inhalation use only. Date of first authorisation/renewal of the authorisation 6.6 Special precautions for disposal and other handling.4.7 Effects on ability to drive and use machines.4.5 Interaction with other medicinal products and other forms of interaction.4.4 Special warnings and precautions for use.4.2 Posology and method of administration.Show table of contents Hide table of contents

Ventolin hfa 90 mcg inhaler